PROCEPT BioRobotics (PRCT) Competitors $56.83 -2.35 (-3.97%) As of 03:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRCT vs. PEN, STVN, GKOS, NARI, INSP, IRTC, BLCO, TMDX, SLNO, and NVSTShould you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), and Envista (NVST). These companies are all part of the "medical equipment" industry. PROCEPT BioRobotics vs. Penumbra Stevanato Group Glaukos Inari Medical Inspire Medical Systems iRhythm Technologies Bausch + Lomb TransMedics Group Soleno Therapeutics Envista PROCEPT BioRobotics (NASDAQ:PRCT) and Penumbra (NYSE:PEN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, community ranking, institutional ownership, media sentiment and risk. Does the media refer more to PRCT or PEN? In the previous week, Penumbra had 13 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 21 mentions for Penumbra and 8 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 1.56 beat Penumbra's score of 1.08 indicating that PROCEPT BioRobotics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Penumbra 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is PRCT or PEN more profitable? Penumbra has a net margin of 1.17% compared to PROCEPT BioRobotics' net margin of -50.07%. Penumbra's return on equity of 9.74% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets PROCEPT BioRobotics-50.07% -38.57% -26.06% Penumbra 1.17%9.74%7.35% Which has preferable valuation and earnings, PRCT or PEN? Penumbra has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPROCEPT BioRobotics$249.12M13.14-$105.90M-$1.70-34.81Penumbra$1.24B8.78$90.95M$1.06265.13 Does the MarketBeat Community prefer PRCT or PEN? Penumbra received 797 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. Likewise, 80.36% of users gave Penumbra an outperform vote while only 70.00% of users gave PROCEPT BioRobotics an outperform vote. CompanyUnderperformOutperformPROCEPT BioRoboticsOutperform Votes4270.00% Underperform Votes1830.00% PenumbraOutperform Votes83980.36% Underperform Votes20519.64% Do analysts rate PRCT or PEN? PROCEPT BioRobotics presently has a consensus target price of $90.00, suggesting a potential upside of 52.08%. Penumbra has a consensus target price of $302.40, suggesting a potential upside of 7.60%. Given PROCEPT BioRobotics' higher probable upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88 Which has more volatility & risk, PRCT or PEN? PROCEPT BioRobotics has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Do insiders and institutionals have more ownership in PRCT or PEN? 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 17.4% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 4.2% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryPenumbra beats PROCEPT BioRobotics on 13 of the 19 factors compared between the two stocks. Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRCT vs. The Competition Export to ExcelMetricPROCEPT BioRoboticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.28B$4.55B$5.43B$8.48BDividend YieldN/A43.65%5.22%4.11%P/E Ratio-30.3529.8726.8320.05Price / Sales13.1471.05392.35116.46Price / CashN/A51.0838.2534.62Price / Book10.646.346.874.61Net Income-$105.90M$67.64M$3.22B$248.19M7 Day Performance8.05%21.94%6.76%2.97%1 Month Performance10.76%26.54%13.66%16.58%1 Year Performance-13.86%22.75%18.27%8.16% PROCEPT BioRobotics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRCTPROCEPT BioRobotics2.9744 of 5 stars$56.83-4.0%$90.00+58.4%-13.9%$3.15B$249.12M-29.20430Positive NewsGap UpPENPenumbra4.7276 of 5 stars$296.98-0.1%$302.40+1.8%+39.5%$11.50B$1.24B873.473,900Positive NewsSTVNStevanato Group1.2589 of 5 stars€23.64-1.5%N/A+21.2%$7.16B$1.10B50.304,650GKOSGlaukos4.6725 of 5 stars$94.57+5.1%$134.67+42.4%-10.7%$5.40B$404.52M-32.95780News CoveragePositive NewsGap UpNARIInari Medical0.4726 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News CoverageINSPInspire Medical Systems4.7097 of 5 stars$156.54+3.5%$211.91+35.4%-3.4%$4.62B$840.11M90.49760Positive NewsGap UpIRTCiRhythm Technologies1.3035 of 5 stars$137.80+0.1%$128.55-6.7%+52.5%$4.40B$618.59M-37.861,790Positive NewsBLCOBausch + Lomb4.3042 of 5 stars$11.91+5.6%$15.50+30.2%-19.2%$4.21B$4.83B-13.0812,500Gap UpTMDXTransMedics Group1.4408 of 5 stars$118.73+6.5%$126.70+6.7%-10.0%$4.02B$488.23M126.31210Gap UpSLNOSoleno Therapeutics4.8601 of 5 stars$76.70-0.1%$106.78+39.2%+59.6%$3.87BN/A-23.1030News CoveragePositive NewsNVSTEnvista4.0351 of 5 stars$18.56+5.5%$20.08+8.2%-2.7%$3.15B$2.50B-2.8612,700Positive NewsGap Up Related Companies and Tools Related Companies PEN Competitors STVN Competitors GKOS Competitors NARI Competitors INSP Competitors IRTC Competitors BLCO Competitors TMDX Competitors SLNO Competitors NVST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRCT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRCT Stock Free PRCT Stock Alerts